Applicability and efficacy of a model for prevention of perinatal transmission of hepatitis B virus infection: Single center study in Egypt

doi:10.3748/wjg.v20.i45.17075

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 45

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9702)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

406

WORD

357

HTML

5870

Figures (1-2)

262

Tables (1-4)

213

Sum=7108

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1216

Download

1378

Sum=2594

Dec 7, 2014 (publication date) through Jan 19, 2025

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Research Report

World J Gastroenterol. Dec 7, 2014; 20(45): 17075-17083
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17075

Table 3 Hepatitis B immunoglobulin and hepatitis B vaccine administered to the infants born to hepatitis B virus surface antigen positive women n (%)

		Age of administration	n = 34
HBIG	Not Given		3 (8.8)
	Given	1^st 12 h	22 (64.7)
		12-24 h	4 (11.8)
		24-48 h	5 (14.7)
HBV vaccine	1^st dose	1^st dose within 48 h of delivery	31 (91.2)
		1^st dose at the age of 9 d	1 (2.9)
		1^st dose at the age of 2 mo	2 (5.9)
	2^nd dose	2^nd dose at age 1 mo	32 (94.1)
	2^nd dose	2^nd dose at age 4 mo	2 (5.9)
	3^rd dose	3^rd dose at 6 mo	31 (91.2)
	4^th dose	4^th dose at 7 mo	3 (8.8)

HBIG: Hepatitis B immunoglobulin; HBV: Hepatitis B virus.

Citation: El-Karaksy HM, Mohsen LM, Saleh DA, Hamdy MS, Yassin NA, Farouk M, Salit ME, El-Shabrawi MH. Applicability and efficacy of a model for prevention of perinatal transmission of hepatitis B virus infection: Single center study in Egypt. World J Gastroenterol 2014; 20(45): 17075-17083
URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17075.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i45.17075